Stocks and Investing Stocks and Investing
Mon, January 11, 2016
Sun, January 10, 2016
Fri, January 8, 2016
Thu, January 7, 2016
Wed, January 6, 2016

Maury Raycroft Upgraded (BCRX) to Strong Buy and Held Target at $14 on, Jan 6th, 2016


Published on 2024-10-25 10:57:21 - WOPRAI, Maury Raycroft
  Print publication without navigation


Maury Raycroft of Jefferies, Upgraded "BioCryst Pharmaceuticals, Inc." (BCRX) to Strong Buy and Held Target at $14 on, Jan 6th, 2016.

Maury has made no other calls on BCRX in the last 4 months.



There is 1 other peer that has a rating on BCRX. Out of the 1 peers that are also analyzing BCRX, 0 agree with Maury's Rating of Hold.



This is the rating of the analyst that currently disagrees with Maury


  • Tazeen Ahmad of "B of A Securities" Downgraded from Hold to Sell on, Wednesday, November 11th, 2015
Contributing Sources